From February 6, 2024 to March 31, 2024, the company has repurchased 99,900 shares, representing 0.02% for CNY 2.94 million. With this, the company has completed the repurchase of 99,900 shares, representing 0.02% for CNY 2.94 million under the buyback announced on February 7, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.83 CNY | +0.91% | +9.72% | +8.09% |
May. 07 | China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7% | MT |
May. 07 | BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.09% | 2.19B | |
+38.48% | 723B | |
+34.28% | 595B | |
-4.44% | 369B | |
+20.09% | 332B | |
+2.26% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.05% | 168B |
- Stock Market
- Equities
- 688166 Stock
- News BrightGene Bio-Medical Technology Co., Ltd.
- Tranche Update on BrightGene Bio-Medical Technology Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.